[A case report of residual gastric cancer 15 years after pancreatoduodenectomy with modified child's reconstruction].
A 75-year-old man underwent pancreatoduodenectomy for pancreatic cancer. He had presented with epigastralgia in June 2008. Gastrointestinal endoscopy revealed type 2 gastric cancer in the cardiac area. Enhanced abdominal CT scanning confirmed an enhanced mass in the cardiac area. Gastrectomy with Roux-en-Y reconstruction was performed for residual gastric cancer. Histopathological findings revealed, pT3(SS), pN0, pH0, pP0, pStageIIA. Single-agent TS-1 therapy was chosen as adjuvant chemotherapy but was changed to TS-1+CDDP because of CT-detected recurrence 3 months after the second operation. After a 6 month course of chemotherapy, complete reduction of the tumor was obtained.
Dept. of Surgery, Kansai Medical University.
Masanori
M
Yamada
Koji
K
Nakai
Kentaro
K
Inoue
Takashi
T
Matsuura
Hidesuke
H
Yanagida
Hiroaki
H
Kitade
Kazuhiko
K
Yoshioka
Madoka
M
Hamada
A-Hon
AH
Kwon
D000368:Aged; D000713:Anastomosis, Roux-en-Y; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005743:Gastrectomy; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D018365:Neoplasm, Residual / Q000188:drug therapy / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D016577:Pancreaticoduodenectomy; D019651:Plastic Surgery Procedures; D017640:Silicates / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D014025:Titanium / Q000008:administration & dosage
D017640:Silicates; C103828:titanium silicide; D014025:Titanium; D002945:Cisplatin